Amplifying the Patient Voice: Reflections from MAPS EMEA 2025
At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
Simple Considerations before Determining S&P Objectives for Medical Devices
With all the things to consider with Medical Device Regulations, it's important to identify the...
Bite-Sized Content Helps Avoid User Fatigue – How Can Pharma Use It?
Today's readers tend to avoid long pharma content and medical jargon. If you want to...
Why the Healthcare Industry MUST Care About the Caregiver
Caregivers are vital in the treatment of a patient, whether at home or in a...
The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents
Better patient awareness has led to a rapid increase in the number of MI requests...
Ways Pharma Showed Patients How They Matter
Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...